Seda Eminaga

1.3k total citations
18 papers, 909 citations indexed

About

Seda Eminaga is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Seda Eminaga has authored 18 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Cardiology and Cardiovascular Medicine and 3 papers in Immunology. Recurrent topics in Seda Eminaga's work include Cardiomyopathy and Myosin Studies (4 papers), Protein Tyrosine Phosphatases (3 papers) and MicroRNA in disease regulation (3 papers). Seda Eminaga is often cited by papers focused on Cardiomyopathy and Myosin Studies (4 papers), Protein Tyrosine Phosphatases (3 papers) and MicroRNA in disease regulation (3 papers). Seda Eminaga collaborates with scholars based in United States, United Kingdom and Israel. Seda Eminaga's co-authors include Jonathan G. Seidman, Danos C. Christodoulou, Christine E. Seidman, Anton M. Bennett, Joshua Gorham, Hiroko Wakimoto, François Vigneault, George M. Church, Tetsuo Konno and Polakit Teekakirikul and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Seda Eminaga

17 papers receiving 904 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Seda Eminaga United States 11 592 396 142 101 86 18 909
Hesther de Ruiter Netherlands 10 546 0.9× 251 0.6× 71 0.5× 63 0.6× 61 0.7× 15 738
Tatiana Tsoutsman Australia 15 360 0.6× 377 1.0× 64 0.5× 103 1.0× 34 0.4× 23 709
Jasmine Healy Canada 17 709 1.2× 301 0.8× 86 0.6× 82 0.8× 131 1.5× 31 1.0k
Marta Roche-Molina Spain 11 398 0.7× 139 0.4× 131 0.9× 251 2.5× 105 1.2× 18 851
Serena Banfi United States 12 458 0.8× 748 1.9× 227 1.6× 54 0.5× 71 0.8× 13 1.1k
Greg P. Boivin United States 16 864 1.5× 739 1.9× 87 0.6× 35 0.3× 80 0.9× 23 1.2k
Tie Ke China 16 704 1.2× 258 0.7× 89 0.6× 29 0.3× 40 0.5× 35 913
Sudeshna Fisch United States 12 666 1.1× 189 0.5× 157 1.1× 30 0.3× 32 0.4× 25 919
Belaïd Sekkali Belgium 15 603 1.0× 145 0.4× 48 0.3× 62 0.6× 52 0.6× 21 854
Radiance Lim Singapore 8 511 0.9× 65 0.2× 206 1.5× 119 1.2× 77 0.9× 9 765

Countries citing papers authored by Seda Eminaga

Since Specialization
Citations

This map shows the geographic impact of Seda Eminaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seda Eminaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seda Eminaga more than expected).

Fields of papers citing papers by Seda Eminaga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seda Eminaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seda Eminaga. The network helps show where Seda Eminaga may publish in the future.

Co-authorship network of co-authors of Seda Eminaga

This figure shows the co-authorship network connecting the top 25 collaborators of Seda Eminaga. A scholar is included among the top collaborators of Seda Eminaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seda Eminaga. Seda Eminaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Cho, Hyun‐Ju, Christopher Switzer, Eleni Louka, et al.. (2025). SFX-01 is therapeutic against myeloproliferative disorders caused by activating mutations in Shp2. EMBO Molecular Medicine. 17(8). 2115–2136.
2.
Barwari, Temo, Xiaoke Yin, Sarah R. Langley, et al.. (2023). Inhibition of miR-199a-3p in a murine hypertrophic cardiomyopathy (HCM) model attenuates fibrotic remodeling. SHILAP Revista de lepidopterología. 6. 100056–100056. 4 indexed citations
3.
Eminaga, Seda, et al.. (2021). Phosphorylation at Serines 157 and 161 Is Necessary for Preserving Cardiac Expression Level and Functions of Sarcomeric Z-Disc Protein Telethonin. Frontiers in Physiology. 12. 732020–732020. 2 indexed citations
4.
Aksentijević, Dunja, Anja Karlstaedt, Marina Basalay, et al.. (2020). Intracellular sodium elevation reprograms cardiac metabolism. Nature Communications. 11(1). 4337–4337. 63 indexed citations
5.
Barwari, Temo, Seda Eminaga, Paul C. Armstrong, et al.. (2017). Abstract 19935: MicroRNA-21 Regulates Transforming Growth Factor Beta-1 Release From Platelets: A Novel Mechanism for the Anti-Fibrotic Effects of MicroRNA-21 Inhibition. Circulation. 1 indexed citations
6.
Burke, Michael A., Stephen Chang, Hiroko Wakimoto, et al.. (2016). Molecular profiling of dilated cardiomyopathy that progresses to heart failure. JCI Insight. 1(6). 73 indexed citations
7.
Eminaga, Seda, Polakit Teekakirikul, Christine E. Seidman, & Jonathan G. Seidman. (2016). Detection of Cell Proliferation Markers by Immunofluorescence Staining and Microscopy Imaging in Paraffin‐Embedded Tissue Sections. Current Protocols in Molecular Biology. 115(1). 14.25.1–14.25.14. 16 indexed citations
8.
Eminaga, Seda, et al.. (2014). Safety of intrathecal administration of cytosine arabinoside and methotrexate in dogs and cats. Veterinary and Comparative Oncology. 14(3). 331–336. 7 indexed citations
9.
Eminaga, Seda, et al.. (2014). Serum bromide concentrations following loading dose in epileptic dogs. Journal of Small Animal Practice. 55(2). 108–111. 7 indexed citations
10.
Eminaga, Seda, Danos C. Christodoulou, François Vigneault, George M. Church, & J.G. Seidman. (2013). Quantification of microRNA Expression with Next‐Generation Sequencing. Current Protocols in Molecular Biology. 103(1). Unit 4.17–Unit 4.17. 52 indexed citations
11.
Vigneault, François, Dmitry Ter‐Ovanesyan, Shahar Alon, et al.. (2012). High‐Throughput Multiplex Sequencing of miRNA. Current Protocols in Human Genetics. 73(1). 11.12.1–11.12.10. 34 indexed citations
12.
Alon, Shahar, François Vigneault, Seda Eminaga, et al.. (2011). Barcoding bias in high-throughput multiplex sequencing of miRNA. Genome Research. 21(9). 1506–1511. 89 indexed citations
13.
Pravenec, Michal, Václav Zı́dek, Vladimír Landa, et al.. (2011). Age-related autocrine diabetogenic effects of transgenic resistin in spontaneously hypertensive rats: gene expression profile analysis. Physiological Genomics. 43(7). 372–379. 5 indexed citations
14.
Teekakirikul, Polakit, Seda Eminaga, Okan Toka, et al.. (2010). Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β. Journal of Clinical Investigation. 120(10). 3520–3529. 353 indexed citations
15.
Konno, Tetsuo, Dan Chen, Libin Wang, et al.. (2010). Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathy. Proceedings of the National Academy of Sciences. 107(42). 18097–18102. 42 indexed citations
16.
Eminaga, Seda & Anton M. Bennett. (2008). Noonan Syndrome-associated SHP-2/Ptpn11 Mutants Enhance SIRPα and PZR Tyrosyl Phosphorylation and Promote Adhesion-mediated ERK Activation. Journal of Biological Chemistry. 283(22). 15328–15338. 35 indexed citations
17.
Kontaridis, Maria, Seda Eminaga, Mara Fornaro, et al.. (2004). SHP-2 Positively Regulates Myogenesis by Coupling to the Rho GTPase Signaling Pathway. Molecular and Cellular Biology. 24(12). 5340–5352. 80 indexed citations
18.
Schwartz, Marc F., Soo-Jung Lee, Jimmy Duong, Seda Eminaga, & David F. Stern. (2003). FHA Domain-Mediated DNA Checkpoint Regulation of Rad53. Cell Cycle. 2(4). 381–394. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hesther de Ruiter Breakdown of academic impact, for papers by Tatiana Tsoutsman Breakdown of academic impact, for papers by Jasmine Healy Breakdown of academic impact, for papers by Marta Roche-Molina Breakdown of academic impact, for papers by Serena Banfi Breakdown of academic impact, for papers by Greg P. Boivin Breakdown of academic impact, for papers by Tie Ke Breakdown of academic impact, for papers by Sudeshna Fisch Breakdown of academic impact, for papers by Belaïd Sekkali Breakdown of academic impact, for papers by Radiance Lim
Rankless by CCL
2026